首页 | 官方网站   微博 | 高级检索  
     

口腔颌面部鳞癌SNCG、MMP-9的表达及其临床意义
引用本文:薛昌敖,张建华,刘炜,吴煜农.口腔颌面部鳞癌SNCG、MMP-9的表达及其临床意义[J].口腔生物医学,2014,0(2):78-81.
作者姓名:薛昌敖  张建华  刘炜  吴煜农
作者单位:薛昌敖 (南京医科大学附属南京第一医院口腔科,江苏 南京,210006); 张建华 (南京医科大学附属南京第一医院口腔科,江苏 南京,210006); 刘炜 (南京医科大学附属南京第一医院口腔科,江苏 南京,210006); 吴煜农 (南京医科大学口腔医学研究所·附属口腔医院口腔颌面外科,江苏 南京 210029);
摘    要:目的:探讨神经突触核蛋白-γ(synuclein gamma,SNCG)及基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)在鳞状细胞癌及癌旁组织的表达,分析其与肿瘤的临床及病理特征相关性。方法:采用免疫组化 EnVision 二步法检测150例鳞状细胞癌及癌旁组织中 SNCG 及 MMP-9的表达。结果:口腔颌面部鳞癌组织中的 SNCG 及 MMP-9的阳性率分别为78.0%(117/150)及68.68%(103/150),而癌旁组织中 SNCG及 MMP-9的阳性率分别为8.0%(11/150)及14.0%(21/150),均有显著性差异(P<0.001)。低分化、中分化肿瘤的 SNCG及 MMP-9的表达阳性率显著高于高分化肿瘤中的阳性率(P<0.001),然而低分化与中分化肿瘤之间 SNCG及 MMP-9的表达阳性率无显著性差异(P>0.05)。肿瘤分期分析结果显示,Ⅲ~Ⅳ期SNCG及 MMP-9的表达阳性率显著高于Ⅰ~Ⅱ期,有显著性差异(SNCG:χ^2=4.20,P=0.041;MMP-9:χ^2=26.66,P=0.000)。转移的肿瘤组织中的SNCG及MMP-9的表达阳性率分别为90.77%和93.85%,高于其在无转移的肿瘤组织表达阳性率,有显著性差异(SNCG:χ^2=10.09,P=0.001;MMP-9:χ^2=33.80,P=0.000)结论:SNCG、MMP-9在与口腔颌面部鳞癌中呈现高表达,与肿瘤的病理与临床分级、分期呈正相关,提示检测口腔颌面部鳞癌组织中 SNCG及 MMP-9的表达可以为肿瘤的病情进展和预后判断提供依据。

关 键 词:神经γ突触核蛋白  基质金属蛋白酶-9  口腔颌面部鳞癌  免疫组化

Expression of SNCG and MMP-9 in oral and maxillofacial carcinoma and its clinical significance
XUE Changao,ZHANG Jianhua,LIU Wei,WU Yunong.Expression of SNCG and MMP-9 in oral and maxillofacial carcinoma and its clinical significance[J].Oral Biomedicine,2014,0(2):78-81.
Authors:XUE Changao  ZHANG Jianhua  LIU Wei  WU Yunong
Affiliation:1. Department of Stomatology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China ;2. Institute of Stomatology, Department of Oral and Maxillofacial Surgery ,Affiliated Hospital of Stomatology , Nanfing Medical University, Nanjing 210029, China )
Abstract:Objective:To analyze the correlation between synuclein gamma (SNCG)and matrix metalloproteinase-9 (MMP-9)and the clinicopathological features of tumor,we investigated the expression of SNCG and MMP-9 in oral and maxillofacial carcinoma and its adjacent tissues.Methods:Immunohistochemistry method was used to detect the expression of SNCG and MMP-9 in oral and maxillofacial carcinoma and its adjacent tissues.Results:The incidence rate of SNCG and MMP-9 in oral and maxillofacial carcinoma was 78.0% (1 17/150)and 68.68%(103/150),respectively.While that of SNCG and MMP-9 in its adjacent tissues was 8.0%(1 1/150) and 14.0%(21/150),respectively.There were significantly differences in SNCG and MMP-9 between them(P 〈0.001).The inci-dence rates of SNCG and MMP-9 were higher in poorly or medium differentiated (P〈0.001 ).However,the expression of SNCG and MMP-9 between poorly differentiated and well differentiated carcinoma had no significant difference.According to stages,the incidence rates of SNCG and MMP-9 in Ⅲ-Ⅳ period were significantly higher than those inⅠ-Ⅱ period,and there were significant difference (SNCG:χ^2 =4.20,P=0.041;MMP-9:χ^2 =26.66,P=0.000).The expression of SNCG and MMP-9 in metastatic tumor were higher (SNCG:90.77%;MMP-9:93.85% )than that in non-metastatic tumor (SNCG:68.24%;MMP-9:49.41%),and there were significant difference(SNCG:χ^2 =10.09,P=0.0014;MMP-9:χ^2 =33.80,P=0.000).Conclusions:The excessive expression of SNCG and MMP-9 in oral and maxillofacial carcinoma,which was positively associated with the pathologic process,differentiation degree of carcinoma,and TNM stages of tumor.The expression of SNCG and MMP-9 are expected to be the marker in the tumor of oral and maxil-lofacial carcinoma for the judgment of advancement and prognosis.
Keywords:Synuclein gamma  Matrix metalloproteinase-9  Oral and maxillofacial carcinoma  Immunohistochemistry
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号